AGC Biologics Seattle Facility Achieves Milestone Year with Regulatory Approvals, Customer Satisfaction and Zero-Finding ISO Certification Inspection

AGC Biologics’ Seattle facility achieved key 2025 milestones, including passing a US FDA inspection after three Biologics License Application approvals. It earned ISO 45001 and 14001 certifications with zero findings, secured regulatory approvals in ten countries, completed six customer audits, and maintained a 100% batch success rate, underscoring its quality and reliability.